Login / Signup

Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context.

Gwendolien VanderschaegheJolien SchaeverbekeRose BruffaertsRik VandenbergheKris Dierickx
Published in: Alzheimer's research & therapy (2017)
This exploratory study shows that the majority of patients can accurately recall the information received during disclosure. The experienced advantages and disadvantages reported by our patients depended on the outcome of the result (positive or negative) and the interval of the conducted interview (2 weeks or 6 months after amyloid PET disclosure). Discrepancies were found between patients' expectations according to the interview prior to amyloid PET disclosure (Vanderschaeghe et al. [Neuroethics. 2017;10:281-97]) and their actual experiences after their amyloid PET disclosure.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • computed tomography
  • prognostic factors
  • peritoneal dialysis
  • healthcare
  • pet ct
  • pet imaging
  • health information